Search Within

Timothy J Akhurst

Formats
  1. Journal Article (85)
  2. Meeting Abstract (49)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Radiology, Department of (89)
  2. Sloan Kettering Institute Faculty (84)
  3. GSK Faculty (82)
  4. Molecular Pharmacology and Chemistry Program Faculty (82)
  5. Molecular Imaging and Therapy Service (79)
  6. Surgery (67)

More Groups

People
  1. Steven Larson (77)
  2. Henry Yeung (27)
  3. Ronald Finn (26)
  4. Homer Macapinlac (23)
  5. Mithat Gonen (19)
  6. Yuman Fong (19)

More People

Years
  1. 2022 (1)
  2. 2019 (2)
  3. 2016 (1)
  4. 2013 (2)
  5. 2012 (2)
  6. 2011 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (24)
  2. Journal of Clinical Oncology (17)
  3. Annals of Surgical Oncology (8)
  4. Clinical Positron Imaging (6)
  5. European Journal of Nuclear Medicine (6)
  6. Journal of Thoracic Oncology (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (24)
  2. Elsevier Inc. (19)
  3. American Society of Clinical Oncology (17)
  4. Springer (13)
  5. Lippincott Williams & Wilkins (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (139)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • [F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer
    Meeting Abstract

    Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG PET. Iterative reconstruction segmented attenuation correction (IRSAC) allows greater detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Colsher, J.; Crandall, P.; MacApinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Utility of (18)F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
    Journal Article

    Fong, Y.; Saldinger, P. F.; Akhurst, T.; Macapinlac, H.; Yeung, H.; Finn, R. D.; Cohen, A.; Kemeny, N.; Blumgart, L. H.; Larson, S. M.
    American Journal of Surgery (1999)

    Fulltext@MSK | Save
  • Positron emission tomography imaging of colorectal cancer
    Journal Article

    Akhurst, T.; Larson, S. M.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer
    Journal Article

    Liberman, L.; Cody, H. S. 3rd; Hill, A. D. K.; Rosen, P. P.; Yeh, S. D. J.; Akhurst, T.; Morris, E. A.; Abramson, A. F.; Borgen, P. I.; Dershaw, D. D.
    Radiology (1999)

    Fulltext@MSK | Save
  • [(18)F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels
    Journal Article

    Wang, W.; Macapinlac, H.; Larson, S. M.; Yeh, S. D. J.; Akhurst, T.; Finn, R. D.; Rosai, J.; Robbins, R. J.
    Journal of Clinical Endocrinology and Metabolism (1999)

    Fulltext@MSK | Save
  • PET scanning with (18)F 2-fluoro-2-deoxy-D-glucose (FDG) in patients with melanoma: Benefits and limitations
    Journal Article

    Nguyen, A. T.; Akhurst, T.; Larson, S. M.; Coit, D. G.; Brady, M. S.
    Clinical Positron Imaging (1999)

    Fulltext@MSK | Save
  • Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: The visual response score and the change in total lesion glycolysis
    Journal Article

    Larson, S. M.; Erdi, Y.; Akhurst, T.; Mazumdar, M.; Macapinlac, H. A.; Finn, R. D.; Casilla, C.; Fazzari, M.; Srivastava, N.; Yeung, H. W. D.; more...
    Clinical Positron Imaging (1999)

    Fulltext@MSK | Save